Skip to main content

section

Language & Country Selector for Desktop

Choose Location

International
Americas
Europe
Middle East & Africa
Asia Pacific

Global | en
Sandoz | en
Novartis Foundation | en

Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | es

Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en

Egypt | en
Israel | he
South Africa | en
Turkey | tr

Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh

Language & Country Selector for Mobile

Choose Location

International Americas Europe Middle East & Africa Asia Pacific

About

Board of Directors

Joerg Reinhardt

Simon Moroney

Nancy Andrews

Ton Buechner

Patrice Bula

Elizabeth Doherty

Ana de Pro Gonzalo

Bridgette Heller

Daniel Hochstrasser

Frans van Houten

Andreas von Planta

Charles Sawyers

William Winters

Charlotte Pamer-Wieser

Executive Committee

Vasant Narasimhan

Shreeram Aradhye

James Bradner

Victor Bulto

Karen Hale

Harry Kirsch

Rob Kowalski

Steffen Lang

Klaus Moosmayer

Richard Saynor

Marie-France Tschudin

Lutz Hegemann

Michael Willi

Kees Roks

Strategy

People and Culture

Data and Digital

Products

Innovative Medicines

Sandoz

Operations

Global Biotech Cooperations

Diversity & Inclusion

Equity

Diversity & Inclusion Governance and Community

Inclusivity

Parental Leave

Society

Quality

Audit program

Novartis Quality Management System (QMS)

Product and patient safety training

Regulatory inspections

Product recalls

Third-party suppliers

About Novartis

Patients and Caregivers

Novartis Commitment to Patients and Caregivers

Diseases

Patient Organization Funding

Adverse Event Reporting

COVID-19: Patients and Caregivers

Stories: Patients Perspectives

Patients & Caregivers

Healthcare Professionals

Medical Congresses and Events

Abstract summaries for EULAR

Abstract summaries for ACR

Abstract summaries for EADV

Products

Novartis Pipeline

Managed Access Programs

Novartis Gene Therapies Managed Access Program

Novartis External Funding

Healthcare Professional Resources by Country

Investigator-Initiated Trials / Studies

Transparency and Disclosure

Novartis Medical Information

Submit medical enquiry

Healthcare Professionals

Research & Development

Novartis Institutes for BioMedical Research

Collaborations

NIBR Global Scholars Program

Technology Platforms

Radioligand Therapy

Gene Therapy

Cell Therapy

Research Disease Areas

Immuno-oncology research at Novartis

Oncology research at Novartis

Cardiovascular and metabolic disease research at Novartis

Autoimmunity, transplantation and inflammatory disease research at Novartis

Ophthalmology research at Novartis

Neuroscience Research at Novartis

Musculoskeletal Disease Research at Novartis

DAx: exploratory disease research at Novartis

Research Locations

Novartis Institute for Tropical Diseases

Novartis Pipeline

Translational Medicine

Research & Development Approach

Stories from our Labs

Open Source Science

Research & Development

ESG

Access

Creating sustainable business models

Value-Based Pricing

Sub-Saharan Africa

Donations

Novartis Access Principles

Novartis Oncology Access

Patents and Licensing

Ethics, Risk and Compliance

Ethical Behavior

Compliance

Human Rights

Learning and Engagement

Risk management

Environmental Sustainability

Climate

Waste

Water

Global Health

Anti-Microbial Resistance (AMR)

Avoidable Blindness

Chagas Disease

Leprosy

Malaria

Sickle Cell Disease (SCD)

Novartis Foundation

Diversity & Inclusion

Reporting

Environmental, Social and Governance (ESG) Index

ESG Rating Performance

Codes, Policies and Guidelines

Materiality Assessment

Transparency and Disclosure

Targets

Positions

Environmental, Social and Governance

Investors

Event Calendar

Financial Data

Novartis Annual Results

Novartis Quarterly Results

Novartis SEC Filings

Product Sales

Fixed-Income Securities

Expected Currency Impact

Share Data & Analysis

Share Monitor

Dividend Information

Share Ownership

Share Overview

Shareholder Information

General Meetings

American Depository Receipts (ADR)

Share Buy-Back

Frequently Asked Questions

Company Overview

Corporate Governance

Novartis Annual Reporting Suite

Reporting Archive

Publications Order Form

ESG

Investors

News

News Archive

Media Library

Stories

Subscribe

News

Careers

Career Search

Our Teams

Careers in Commercial

Careers in Communications and Advocacy

Careers in Consulting

Careers in Digital

Careers in Health, Safety & Environment

Careers in Information Technology (IT)

Careers in Medical & Development

Careers in People & Organization

Careers in Procurement

Careers in Research

Careers in Strategy

Careers in Manufacturing and Supply

Ethics, Risk & Compliance (ERC)

Careers in Legal

Career Programs

Community Exploration & Learning Lab (CELL)

Early Talent

Postdoc Program

Andreas Bender, PhD

Boxun Lu, PhD

The Novartis Innovation Postdoctoral Fellowship

The Novartis Discovery Postdoctoral Fellowship

Postdoc Research Themes

Recognition

Postdoc Program Leadership

International Careers

Learning and Development

Well-being

Internship Programs

Careers

COVID-19 Information Center

COVID-19 Novartis response

Clinical Trials

Clinical Trials

Partnering

Partnering

Contacts

Contacts
Home

Home
News
Novartis Access perspectives: Kenya's New Health Care Battle

Novartis Access perspectives: Kenya's New Health Care Battle

Jul 06, 2016

An opinion piece by Dr. Samuel Mwenda published in US News & World Report

Jul 06, 2016

Print
PDF

Novartis

Navigate Novartis

Patients and Caregivers
Healthcare Professionals
Researchers
Job Seekers
Journalists
Investors
Partners
Suppliers

Topics

Clinical Trials
COVID-19 Info Center
ESG

Explore

Stories
Diseases
Locations
Products
Novartis Pipeline

Novartis companies

Sandoz
Advanced Accelerator Applications
Gyroscope Therapeutics

Footer Bottom

© 2022 Novartis AG

Terms of Use
Privacy
Contacts
Cookie Settings
Site Map
Web Accessibility
Open Source

Novartis Site Directory

This site is intended for a global audience